Veru (VERU) Interest & Investment Income (2012 - 2015)
Veru (VERU) posted quarterly Interest & Investment Income of -$3841.0 for Q1 2015, down 103.53% year-over-year from $108724.0 in Q1 2014, and down 689.11% quarter-over-quarter from $652.0 in Q4 2014.
Veru (VERU) Interest & Investment Income (2012 - 2015) Analysis & Trends
Veru (VERU) has reported Interest & Investment Income for 4 consecutive years, with -$3841.0 the latest figure, recorded in Q1 2015.
- In Q1 2015, Interest & Investment Income fell 103.53% year-over-year to -$3841.0; the TTM figure through Mar 2015 stood at $6942.0 (down 90.84% YoY), while the FY2014 annual figure was $117123.0, down 52.3% from the prior year.
- Interest & Investment Income fell to -$3841.0 in Q1 2015 per VERU's latest filing, from $652.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $280977.0 in Q1 2013 and bottomed at -$30421.0 in Q3 2013.
- Historically, Interest & Investment Income has averaged $29935.8 across 4 years, with a median of -$659.0 in 2012.
- Annual changes were most pronounced in 2013 — Interest & Investment Income sank 5421.05% — and 2014, when it surged 137.64%.
- Veru's Interest & Investment Income stood at -$4244.0 in 2012, then surged by 59.19% to -$1732.0 in 2013, then surged by 137.64% to $652.0 in 2014, then tumbled by 689.11% to -$3841.0 in 2015.
- Business Quant data shows VERU's Interest & Investment Income at -$3841.0 in Q1 2015, $652.0 in Q4 2014, and $11124.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -3,841.00 |
| Dec 31, 2014 | 652.00 |
| Sep 30, 2014 | 11,124.00 |
| Jun 30, 2014 | -993.00 |
| Mar 31, 2014 | 108,724.00 |
| Dec 31, 2013 | -1,732.00 |
| Sep 30, 2013 | -30,421.00 |
| Jun 30, 2013 | -767.00 |
| Mar 31, 2013 | 280,977.00 |
| Dec 31, 2012 | -4,244.00 |
| Sep 30, 2012 | -551.00 |
| Jun 30, 2012 | 301.00 |